Abstract We conducted a retrospective observational study to demonstrate that switching to insulin degludec from other long-acting insulins reduces the risk of hypoglycaemia events and improves glycaemic control in patients… Click to show full abstract
Abstract We conducted a retrospective observational study to demonstrate that switching to insulin degludec from other long-acting insulins reduces the risk of hypoglycaemia events and improves glycaemic control in patients with type 2 diabetes and stage 2-3B chronic kidney disease.
Keywords:
chronic kidney;
glycaemic control;
type diabetes;
risk hypoglycaemia;
kidney disease;
insulin degludec
Journal Title: Diabetes Research and Clinical Practice
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Diabetes Research and Clinical Practice
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!